Zobrazeno 1 - 3
of 3
pro vyhledávání: '"63"'
Autor:
Gerald Berthet, Elvira Cannizzaro, Raphael Leuvenink, Andreas Woerner, Walter Baer, Daniela Kaiser, Silke Schroeder, Florence Aeschlimann, Ulrich Heininger, Michael Hofer
Publikováno v:
Pediatric Rheumatology Online Journal
Pediatric rheumatology online journal, vol. 14, no. 1, pp. 34
Pediatric rheumatology online journal, vol. 14, no. 1, pp. 34
Background To analyze the clinical presentation and complications of varicella zoster virus (VZV) infection in children with rheumatic diseases treated with immunosuppressive medication such as biological disease-modifying antirheumatic drugs (bDMARD
Autor:
Joan T. Merrill, Erik Rasmussen, Donna Holloway, Jill P. Buyon, Daniel J. Wallace, John Ferbas, Wayne Tsuji, Blaire Cooke, Tsui Chern Cheah, Ellen M. Ginzler, Kameswara Rao V. Kuchimanchi, Michael H. Weisman, William Stohl, Shelley Sims Belouski, R. John Looney, Arunan Kaliyaperumal, Debra Zack
Publikováno v:
Arthritis Research & Therapy
Blisibimod is a potent B cell-activating factor (BAFF) antagonist that binds to both cell membrane-expressed and soluble BAFF. The goal of these first-in-human studies was to characterize the safety, tolerability, and pharmacokinetic and pharmacodyna
Autor:
Berit Feiring, Preben Aavitsland, Bernardo Rafael Guzmán Herrador, Marianne A. Riise Bergsaker, Katrine Borgen
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 12, Iss 1, p 63 (2012)
BMC Infectious Diseases, Vol 12, Iss 1, p 63 (2012)
Background During the 2009-2010 pandemic in Norway, 12 513 laboratory-confirmed cases of pandemic influenza A(H1N1)pdm09, were reported to the Norwegian Surveillance System for Communicable Diseases (MSIS). 2.2 million persons (45% of the population)